Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

Prasanta Kumar Biswas

Biographic Data

ID9000526
NAMEPrasanta Kumar Biswas
GIVEN NAMESPrasanta Kumar
FAMILY NAMEBiswas
SIGNATUREBISWAS P K
AFFILIATIONSInternational Centre for Diarrhoeal Disease Research
ORCID0009-0008-2841-1860
VERIFIEDYes
TOTAL WORKS2
TOTAL CITATIONS0
AUTHOR COUNT2
EDITOR COUNT0
FIRST PUBLICATION YEAR2019
LATEST PUBLICATION YEAR2025
H-INDEX0
  • Evaluation of oral cholera vaccine (Euvichol-Plus) effectiveness against Vibrio cholerae in Bangladesh

    Open Access•Farhana Khanam, Md Taufiqul Islam et al.•ARTICLE•BMJ Global Health•2025

    INTRODUCTION: Millions of Euvichol-Plus doses have been deployed from the global oral cholera vaccine stockpile in over 20 cholera-affected countries. However, information on Euvichol-Plus's effectiveness is limited. Using this vaccine in a cholera epidemic in Dhaka, Bangladesh, provided the opportunity to evaluate the vaccine effectiveness (VE) using a test-negative design. METHODS: A two-dose regimen of Euvichol-Plus was administered to individ…

  • Organization and implementation of an oral cholera vaccination campaign in an endemic urban setting in Dhaka, Bangladesh

    Open Access•Iqbal Ansary Khan, Ashraful Islam Khan et al.•ARTICLE•Global Health Action•2019

    Bangladesh has historically been cholera endemic, with seasonal cholera outbreaks occurring each year. In collaboration with the government of Bangladesh, the Infectious Diseases Division, International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b) initiated operational research to test strategies to reach the high-risk urban population with an affordable oral cholera vaccine (OCV) "ShancholTM" and examine its effectiveness in redu…

No prominent works on this page.

  • Organization and implementation of an oral cholera vaccination campaign in an endemic urban setting in Dhaka, Bangladesh

    Open Access•Iqbal Ansary Khan, Ashraful Islam Khan et al.•ARTICLE•Global Health Action•2019

    Bangladesh has historically been cholera endemic, with seasonal cholera outbreaks occurring each year. In collaboration with the government of Bangladesh, the Infectious Diseases Division, International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b) initiated operational research to test strategies to reach the high-risk urban population with an affordable oral cholera vaccine (OCV) "ShancholTM" and examine its effectiveness in redu…

  • Evaluation of oral cholera vaccine (Euvichol-Plus) effectiveness against Vibrio cholerae in Bangladesh

    Open Access•Farhana Khanam, Md Taufiqul Islam et al.•ARTICLE•BMJ Global Health•2025

    INTRODUCTION: Millions of Euvichol-Plus doses have been deployed from the global oral cholera vaccine stockpile in over 20 cholera-affected countries. However, information on Euvichol-Plus's effectiveness is limited. Using this vaccine in a cholera epidemic in Dhaka, Bangladesh, provided the opportunity to evaluate the vaccine effectiveness (VE) using a test-negative design. METHODS: A two-dose regimen of Euvichol-Plus was administered to individ…

Cholera (2 works) · Cholera vaccine (2 works) · Environmental health (2 works) · Escherichia coli research studies (2 works) · Immunology (2 works) · Medicine (2 works) · Population (2 works) · Vaccination (2 works) · Vibrio bacteria research studies (2 works) · Virology (2 works)

Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae